JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 35 No. 9 1450-1455
© 1994 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by O'Mahony, D.
Right arrow Articles by Coakley, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by O'Mahony, D.
Right arrow Articles by Coakley, D.

The Discriminant Value of Semiquantitative SPECT Data in Mild Alzheimer's Disease

Denis O'Mahony, John Coffey, John Murphy, Neil O'Hare, David Hamilton, Pat Freyne, J. Bernard Walsh and Davis Coakley

Mercer's Institute for Research on Aging
Department of Diagnostic Imaging and Department of Medical Physics and Bioengineering, St. James's Hospital, Dublin, Ireland

Correspondence: For correspondence or reprints contact Dr. Denis O'Mahony, Dept. of Clinical Geratology, Radcliffe Infirmary, Woodstock Rd., Oxford, OX2 6HE, United Kingdom.

ABSTRACT

In most semiquantitative SPECT studies, overlap between groups of patients with Alzheimer's disease (AD) and age-matched elderly controls is such that single posterior cortical perfusion measurements lack sensitivity. In the present study, the value of a combination of semiquantitative temporoparietal SPECT parameters was examined. Methods: Supratentorial transaxial perfusion measurements were obtained in frontal, anterior temporal, posterior temporoparietal and occipital cortical areas in both hemispheres, in a baseline population of 10 healthy elderly controls and 30 mild to moderately impaired AD patients, as well as in a prospective group of 15 patients with mild cognitive impairment, 12 patients with a diagnosis of probable AD and individual cases of multi-infarct dementia, dementia-frontal type and paranoid psychosis. A linear discriminant function (LDF) was calculated from the baseline subjects' data to classify control and AD subjects individually. Results: Highly significant hypoperfusion was noted in both the anterior temporal and posterior temporoparietal regions of interest in the AD group compared with controls, but with significant overlap. Using an LDF incorporating these perfusion measurements in both hemispheres, 10/10 (100%) controls and 26/30 (87%) AD baseline subjects were correctly classified. Using the baseline LDF in the prospective 15 mildly impaired cases, 11/12 new mild AD cases and none of the 3 non-AD cases were classified in the AD group. Conclusion: These results support the use of a combination of semiquantitative SPECT perfusion estimates from cortical areas with predictable pathological involvement in AD in a linear discriminant format in the clinical assessment of patients with suspected AD.

Key Words: Alzheimer's disease • SPECT • discriminant function • analysis




This article has been cited by other articles:


Home page
AJGPHome page
N. J. Dougall, S. Bruggink, and K. P. Ebmeier
Systematic Review of the Diagnostic Accuracy of 99mTc-HMPAO-SPECT in Dementia
Am J Geriatr Psychiatry, December 1, 2004; 12(6): 554 - 570.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
A. Bozzao, R. Floris, M. E. Baviera, A. Apruzzese, and G. Simonetti
Diffusion and Perfusion MR Imaging in Cases of Alzheimer's Disease: Correlations with Cortical Atrophy and Lesion Load
AJNR Am. J. Neuroradiol., June 1, 2001; 22(6): 1030 - 1036.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1994 by the Society of Nuclear Medicine.